Bruce Stroever - 26 Oct 2021 Form 4 Insider Report for Bone Biologics Corp (BBLG)

Reporting relationship: Director
Issuer ticker: BBLG
Reported as of: 26 Oct 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Feb 2022, 05:03:06 UTC
Next SEC filing: 08 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Bruce Stroever

Key filing fact

Bruce Stroever filed Form 4 for Bone Biologics Corp (BBLG) on 28 Feb 2022.

Key facts

This page summarizes Bruce Stroever's Form 4 filing for Bone Biologics Corp (BBLG).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 28 Feb 2022, 05:03.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BBLG transaction Derivative

Non-Employee Stock Option

Award

Transaction value: $0
Shares: +2,949
Change %
Price: $0.000000
Shares after: 2,949
Date: 26 Oct 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,949
Exercise price: $5.25

BBLG transaction Derivative

Non-Employee Stock Option

Award

Transaction value: $0
Shares: +8,722
Change %: +296%
Price: $0.000000
Shares after: 11,671
Date: 01 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,722
Exercise price: $3.52
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .